Germany, Feb. 20 -- Germany based Novo Nordisk Pharma GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - drug discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient concizumab. The value of the contract is worth 21600000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....